-

Auragens Selected as Nevada Business of the Year Recipient for 2025

Auragens’ recognition places them in a class of their own as they revolutionize the industry while keeping the patients and the community as their top priority

HENDERSON, Nev. & PANAMA CITY, Panama--(BUSINESS WIRE)--Auragens, the market leader in stem cell research, development and treatment, was one of only six companies to be recognized in Southern Nevada for this honor.

"Setting new standards for care and maintaining controls well beyond anyone else in the industry may be time consuming, but the results are worth it and people will take note, as they have here.”

Share

Auragens has operations throughout the United States, Central and South America, and has patients that travel to their treatment center, located in Panama City, Panama, from over 40 countries and 6 continents. But Nevada remains their corporate headquarters and Auragens takes pride in calling Nevada home.

“Auragens was chosen by a panel of judges for their efforts on behalf of the Silver State. They were recognized at an event presented by Nevada Business Magazine and sponsored by Nevada State Bank in mid-May,” said Tarah Richardson, Editor-in-Chief, Nevada Business Magazine. She continued, “The organization’s achievements and leadership in the world of medical advancements are an asset to Nevada’s community.”

In the field of Regenerative Medicine and Stem Cell Treatments there have been tremendous breakthroughs and new developments. Auragens has built its incredible reputation by championing the science and putting its patients and their results first. Published in medical journals, teaching at conferences and remaining transparent in all aspects of their medical treatments, Auragens has become the standard bearer for safety and efficacy of stem cell treatments.

“We are very appreciative for the recognition from Nevada Business Magazine and the judges who selected us,” said Auragens President & CEO Dr. Dan Briggs. “These honors help to reinforce our belief that when given opportunity to do the right thing, you take it. Setting new standards for care and maintaining controls well beyond anyone else in the industry may be time consuming, but the results are worth it and people will take note, as they have here.”

About Auragens – Auragens is the market leader in the field of stem cell treatments, research, and development. They operate their own laboratory onsite and are ISO certified while pursuing AABB accreditation and following all cGMP guidelines and FDA related regulations for safety. Treatments are provided at their private state-of-the-art facility in Panama City, Panama and spans the entire 48th floor of a Class A office building in the Beverly Hills of Panama City, known as Punta Pacifica. All science and medicine is overseen by a team of doctors hailing from universities such as Johns Hopkins, Stanford and Notre Dame among others. Published in numerous journals, the recipient of Medical Researcher of the Year and Business of the Year, Auragens is leading in cutting edge Regenerative Medicine with a goal of making their treatments a Standard of Care and available to all in need.

Contacts

For more information: http://www.Auragens.com email us: Info@Auragens.com or call us: 844-888-6717

More News From Auragens

Independent Recognition Reinforces Auragens' Position as a Global Leader in Regenerative Medicine

LAS VEGAS & PANAMA CITY, Panama--(BUSINESS WIRE)--Auragens today announced it has been named Stem Cell Treatment Center of the Year 2026 by Life Sciences Review, becoming the first organization to receive the publication's highest distinction for two consecutive years. While the award recognizes excellence in patient care, it also reflects a broader transformation taking place within regenerative medicine—one in which scientific rigor, manufacturing quality, regulatory oversight, and integrated...

Auragens Achieves AABB Accreditation, Marking Major Milestone in Regenerative Medicine Quality and Patient Safety

LAS VEGAS & PANAMA CITY--(BUSINESS WIRE)--Auragens, a leading regenerative medicine and research institute, today announced that it has achieved accreditation from the Association for the Advancement of Blood & Biotherapies (AABB), a globally recognized organization known for establishing rigorous standards in cellular therapy, biologics, transfusion medicine, and related healthcare services. The accreditation represents a significant achievement for Auragens and reflects the organization's...

Dr. Dan Briggs of Auragens named Entrepreneur Of The Year® 2026 Pacific Southwest finalist by EY US

LAS VEGAS--(BUSINESS WIRE)--Dr. Dan Briggs, founder / CEO of Auragens, has been named a finalist for the Entrepreneur Of The Year 2026 Pacific Southwest Award by Ernst & Young LLP (EY US). Now in its 41st year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and uplifting communities. The program honors entrepreneurs whose innovations drive economic growth and help shape the f...
Back to Newsroom